| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $10.1B | $11.0B | $9.7B | $9.8B | $8.5B | $7.1B | $7.2B | $7.1B |
| Cost of Revenue | $7.3B | $7.7B | $7.0B | $7.1B | $6.3B | $5.4B | $5.6B | $5.4B |
| Gross Profit | $2.8B | $3.3B | $2.7B | $2.6B | $2.2B | $1.6B | $0.4B | $0.4B |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| SG&A Expense | $1.0B | — | — | — | — | — | — | — |
| Operating Income | $0.4B | $1.1B | $1.8B | $1.7B | $1.4B | $-0.1B | $0.8B | $0.8B |
| Net Income | $-0.5B | $0.6B | $1.2B | $1.2B | $1.0B | $-0.4B | $0.1B | $0.2B |
| EPS (Basic) | $-6.22 | $7.45 | $13.27 | $12.85 | $9.61 | $-3.53 | $0.67 | $1.56 |
| EPS (Diluted) | $-6.22 | $7.37 | $13.14 | $12.70 | $9.54 | $-3.53 | $0.66 | $1.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $13.0B | $14.1B | $11.2B | $10.8B | $10.0B | $9.5B | $10.0B | $9.8B |
| Current Assets | $3.3B | $3.4B | $3.9B | $3.6B | $3.1B | $2.6B | $2.1B | $2.0B |
| Cash & Equivalents | $0.3B | $0.4B | $1.6B | $1.1B | $1.0B | $0.7B | $0.2B | $0.1B |
| Total Liabilities | $9.1B | $9.0B | $6.0B | $6.1B | — | — | — | — |
| Current Liabilities | $2.7B | $2.3B | $2.3B | $2.1B | $1.7B | $1.4B | $1.3B | $1.3B |
| Stockholders' Equity | $3.9B | $5.1B | $5.2B | $4.6B | $4.3B | $3.9B | $4.6B | $4.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.8B | $1.9B | $1.7B | $1.8B | $1.5B | $1.1B | $1.0B | $0.8B |
| Investing Cash Flow | $-0.8B | $-3.4B | $-0.4B | $-0.6B | $-0.4B | $-0.2B | $-0.4B | $-1.6B |
| Capital Expenditures | — | — | — | — | — | — | — | — |
| Financing Cash Flow | $-1.1B | $0.3B | $-0.9B | $-1.0B | $-0.9B | $-0.4B | $-0.6B | $0.6B |